4.7 Review

Reversal of myofibroblast differentiation: A review

期刊

EUROPEAN JOURNAL OF PHARMACOLOGY
卷 734, 期 -, 页码 83-90

出版社

ELSEVIER
DOI: 10.1016/j.ejphar.2014.04.007

关键词

Myofibroblast differentiation; Dedifferentiation; Molecular mechanisms; Mediators; Drugs

资金

  1. National Natural Science Foundation of China [81072685, 81272995]
  2. Open Project of National Key Laboratory of Respiratory Diseases of China [2007DA780154F0912]

向作者/读者索取更多资源

It has long been considered that fibrosis and fibroblast-to-myofibroblast differentiation are irreversible processes. However, recent data obtained indicates that tissue fibrosis and fibroblast-to-myofibroblast differentiation can indeed be reversed, which offers the possibility of a new therapeutic approach for fibrotic disorders. Here, we discuss the origin of the myofibroblasts and different aspects of their differentiation, especially the key mediators and TGF beta-induced signaling pathways. We also report here a few factors involved in myofiroblast dedifferentiation and several compounds which can reverse the established dedifferentiated myofibroblast, as examples that provide the reader a glimpse of the current trends of approach for discovering useful anti-fibrotic drugs. (C) 2014 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据